Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis. | Cancer Med | 2023 | 37537783 | PubTator, text mining | PubMed |
| Has-miR-129-5p's Involvement in Different Disorders, from Digestive Cancer to Neurodegenerative Diseases. | Biomedicines | 2023 | 37509697 | PubTator, text mining | PubMed |
| ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy. | Cancer Gene Ther | 2023 | 37495855 | PubTator, text mining | PubMed |
| Advances and Prospects in the Treatment of Pancreatic Cancer. | Int J Nanomedicine | 2023 | 37489138 | PubTator, text mining | PubMed |
| Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. | Int J Mol Sci | 2023 | 37445886 | PubTator, text mining | PubMed |
| The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target. | Cancer Cell Int | 2023 | 37438760 | PubTator, text mining | PubMed |
| New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment. | RSC Adv | 2023 | 37388143 | PubTator, text mining | PubMed |
| Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR-1236-3p/FGF7 axis in breast cancer. | Thorac Cancer | 2023 | 37385973 | PubTator, text mining | PubMed |
| Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37383726 | PubTator, text mining | PubMed |
| The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation. | Front Oncol | 2023 | 37377917 | PubTator, text mining | PubMed |
| Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study. | Cancer Res Commun | 2023 | 37377615 | PubTator, text mining | PubMed |
| Chronic Obstructive Pulmonary Disease Is Associated with Worse Oncologic Outcomes in Early-Stage Resected Pancreatic and Periampullary Cancers. | Biomedicines | 2023 | 37371779 | PubTator, text mining | PubMed |
| IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system. | Proc Natl Acad Sci U S A | 2023 | 37339207 | PubTator, text mining | PubMed |
| MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK [Retraction]. | Cancer Manag Res | 2023 | 37325187 | PubTator, text mining | PubMed |
| Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation. | Microbiol Spectr | 2023 | 37318366 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals tumor antigen and immune subtypes of melanoma. | Oncol Res | 2023 | 37305390 | PubTator, text mining | PubMed |
| USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression. | Transl Oncol | 2023 | 37302347 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia. | Int J Mol Sci | 2023 | 37298150 | PubTator, text mining | PubMed |
| HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies. | Cancers (Basel) | 2023 | 37296866 | PubTator, text mining | PubMed |
Combining WGCNA and machine learning to construct basement membrane-related gene index helps to predict the prognosis and tumor microenvironment of HCC patients and verifies the carcinogenesis of key gene CTSA. | Front Immunol | 2023 | 37287981 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=9